Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 487

1.

Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?

Papalezova KT, Tyler DS, Blazer DG 3rd, Clary BM, Czito BG, Hurwitz HI, Uronis HE, Pappas TN, Willett CG, White RR.

J Surg Oncol. 2012 Jul 1;106(1):111-8. doi: 10.1002/jso.23044. Epub 2012 Feb 6.

PMID:
22311829
2.

Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram.

White RR, Kattan MW, Haney JC, Clary BM, Pappas TN, Tyler DS, Brennan MF.

Ann Surg Oncol. 2006 Nov;13(11):1485-92. Epub 2006 Sep 30.

PMID:
17013688
3.

Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.

Pendurthi TK, Hoffman JP, Ross E, Johnson DE, Eisenberg BL.

Am Surg. 1998 Jul;64(7):686-92.

PMID:
9655283
4.

En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?

Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL.

J Gastrointest Surg. 2002 Mar-Apr;6(2):147-57; discussion 157-8.

PMID:
11992799
5.

Induction gemcitabine and oxaliplatin therapy followed by a twice-weekly infusion of gemcitabine and concurrent external-beam radiation for neoadjuvant treatment of locally advanced pancreatic cancer: a single institutional experience.

Leone F, Gatti M, Massucco P, Colombi F, Sperti E, Campanella D, Regge D, Gabriele P, Capussotti L, Aglietta M.

Cancer. 2013 Jan 15;119(2):277-84. doi: 10.1002/cncr.27736. Epub 2012 Jul 6.

6.

Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease.

Bickenbach KA, Gonen M, Tang LH, O'Reilly E, Goodman K, Brennan MF, D'Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ.

Ann Surg Oncol. 2012 May;19(5):1663-9. doi: 10.1245/s10434-011-2156-7. Epub 2011 Dec 1.

PMID:
22130621
7.

Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer.

Kang CM, Chung YE, Park JY, Sung JS, Hwang HK, Choi HJ, Kim H, Song SY, Lee WJ.

J Gastrointest Surg. 2012 Mar;16(3):509-17. doi: 10.1007/s11605-011-1784-3. Epub 2011 Dec 20.

PMID:
22183861
8.
9.

Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.

Lind PA, Isaksson B, Almström M, Johnsson A, Albiin N, Byström P, Permert J.

Acta Oncol. 2008;47(3):413-20. Epub 2007 Sep 20.

PMID:
17882555
10.

Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.

Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, Levy A.

Arch Surg. 2000 Jan;135(1):81-7; discussion 88.

PMID:
10636353
11.

Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.

You DD, Lee HG, Heo JS, Choi SH, Choi DW.

J Gastrointest Surg. 2009 Sep;13(9):1699-706. doi: 10.1007/s11605-009-0969-5. Epub 2009 Jul 7.

PMID:
19582512
12.

Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.

Golcher H, Brunner T, Grabenbauer G, Merkel S, Papadopoulos T, Hohenberger W, Meyer T.

Eur J Surg Oncol. 2008 Jul;34(7):756-64. doi: 10.1016/j.ejso.2007.11.012. Epub 2008 Jan 10.

PMID:
18191528
13.

Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.

Coia L, Hoffman J, Scher R, Weese J, Solin L, Weiner L, Eisenberg B, Paul A, Hanks G.

Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):161-7.

PMID:
8083109
14.

Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival.

Allendorf JD, Lauerman M, Bill A, DiGiorgi M, Goetz N, Vakiani E, Remotti H, Schrope B, Sherman W, Hall M, Fine RL, Chabot JA.

J Gastrointest Surg. 2008 Jan;12(1):91-100. Epub 2007 Sep 5.

PMID:
17786524
15.

Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience.

Chao C, Hoffman JP, Ross EA, Torosian MH, Eisenberg BL.

Am Surg. 2000 Apr;66(4):378-85; discussion 386. Review.

PMID:
10776876
16.

Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer.

Arvold ND, Ryan DP, Niemierko A, Blaszkowsky LS, Kwak EL, Wo JY, Allen JN, Clark JW, Wadlow RC, Zhu AX, Fernandez-Del Castillo C, Hong TS.

Cancer. 2012 Jun 15;118(12):3026-35. doi: 10.1002/cncr.26633. Epub 2011 Oct 21.

17.

Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy.

Barugola G, Partelli S, Crippa S, Capelli P, D'Onofrio M, Pederzoli P, Falconi M.

Am J Surg. 2012 Feb;203(2):132-9. doi: 10.1016/j.amjsurg.2011.03.008. Epub 2011 Aug 6.

PMID:
21824596
18.

Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.

Massucco P, Capussotti L, Magnino A, Sperti E, Gatti M, Muratore A, Sgotto E, Gabriele P, Aglietta M.

Ann Surg Oncol. 2006 Sep;13(9):1201-8. Epub 2006 Sep 6.

19.

A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators.

Kim R, Tsao R, Tan A, Byrne M, Almhanna K, Lazaryan A, Elson P, Pelley RJ.

J Gastrointest Surg. 2010 Jul;14(7):1159-69. doi: 10.1007/s11605-010-1213-z. Epub 2010 May 6.

PMID:
20446118
20.

Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially locally advanced head pancreatic adenocarcinoma.

Turrini O, Viret F, Moureau-Zabotto L, Guiramand J, Moutardier V, Lelong B, Giovannini M, Delpero JR.

Eur J Surg Oncol. 2009 Dec;35(12):1306-11. doi: 10.1016/j.ejso.2009.06.005. Epub 2009 Jul 3.

PMID:
19576722

Supplemental Content

Support Center